I’m a nurse practitioner working solo in a clinic for a large employer. All of my patients have the same insurance. I’m happy to write whatever medications my patients can get. If it’s not covered by their insurance, they’re not getting it. It’s as simple as that. The insurance companies / PBMs have patients and prescribers by the balls.
Your fancy medication may be a great drug, but if my patient’s insurance won’t cover it at all, and your competitor’s drug is covered and $0 with the savings card, that’s what they’re going to get. No amount of lunches, pleading, pressure is going to change that. I might try to jump through some hoops to get a few of them covered through step therapy, but I’m too busy to do all that for the hundreds of patients I see per month.
The PBMs are a serious problem.
IM future?
Let’s look at several facts that are influencing the PC/IM market, then you decide.
1. Most PCP providers are now employees; part of a large group or IHS. As an employee they most often do not have the latitude to decide under what context (if any) they will see reps. Well established reps with strong past relationships may be able to navigate around this to some degree, but overall the potential for reps tp consistently see prescribers has eroded and likely will continue to, especially as tenured reps retire or leave. Specialists have been more effective in maintaining their own groups and thus have more autonomy.
2. Many routine primary care functions are being handled by NP/PA providers; and yes in many cases there are good generic options for routine conditions. Our doctors serve more as a quarterback/gatekeeper to specialists; the real branded product opportunities lie in the specialty fields.
3. Between guidelines, ins formularies and institutional pressure/incentive to prescribe what is cheap, (not to mention patient requests) it’s a wonder that IM/PC prescribes any branded drugs. You should feel good about the business you get because if not for a rep I don’t believe hardly any brand would be written in primary care.
4. As for PFE specifically, look at the pipeline; not much coming for PCP world.
So, are there other counterbalancing factors omitted? If you wanna stay with PFE I would strive to get into a specialty role. Just my opinion based on the above facts.
In a dystopian future, the totalitarian nation of Panem is divided into 12 districts and the Capitol. Each year two young sales representatives from each district are selected by lottery to participate in The Hunger Games. Part entertainment, part brutal retribution for a past rebellion, the televised games are broadcast throughout Panem. The 24 participants are forced to eliminate their competitors, at random, in a fight to the death while the citizens of Panem are required to watch. Winning means fame and fortune, while losing....IM future?
Let’s look at several facts that are influencing the PC/IM market, then you decide.
1. Most PCP providers are now employees; part of a large group or IHS. As an employee they most often do not have the latitude to decide under what context (if any) they will see reps. Well established reps with strong past relationships may be able to navigate around this to some degree, but overall the potential for reps tp consistently see prescribers has eroded and likely will continue to, especially as tenured reps retire or leave. Specialists have been more effective in maintaining their own groups and thus have more autonomy.
2. Many routine primary care functions are being handled by NP/PA providers; and yes in many cases there are good generic options for routine conditions. Our doctors serve more as a quarterback/gatekeeper to specialists; the real branded product opportunities lie in the specialty fields.
3. Between guidelines, ins formularies and institutional pressure/incentive to prescribe what is cheap, (not to mention patient requests) it’s a wonder that IM/PC prescribes any branded drugs. You should feel good about the business you get because if not for a rep I don’t believe hardly any brand would be written in primary care.
4. As for PFE specifically, look at the pipeline; not much coming for PCP world.
So, are there other counterbalancing factors omitted? If you wanna stay with PFE I would strive to get into a specialty role. Just my opinion based on the above facts.
No, this is exactly why it IS sales. If left to all the background forces a primary care physician would seldom if ever choose a brand over a generic. A good rep is able to convince and persuade a provider to “fight the system” based on the merits of the product and by leveraging their relationship, which includes trust. And by the way if you are going in promoting a broad formulary message like “all your UHC patients can get product x” then you are not credible; there are almost always carve out and exceptions; again if you have sold the provider they have in their mind resolved that the benefits outweigh the potential hassle factor in prescribing.
Stop! Pharma reps are not salespeople. What you just described is "influencing," to impel. Only the pharma industry believes that the sales reps are salespeople. You all are told what to say, when to say it, how to say it, and to whom. There's little thinking involved. You're a marketer. Nothing, more.No, this is exactly why it IS sales. If left to all the background forces a primary care physician would seldom if ever choose a brand over a generic. A good rep is able to convince and persuade a provider to “fight the system” based on the merits of the product and by leveraging their relationship, which includes trust. And by the way if you are going in promoting a broad formulary message like “all your UHC patients can get product x” then you are not credible; there are almost always carve out and exceptions; again if you have sold the provider they have in their mind resolved that the benefits outweigh the potential hassle factor in prescribing.
No, this is exactly why it IS sales. If left to all the background forces a primary care physician would seldom if ever choose a brand over a generic. A good rep is able to convince and persuade a provider to “fight the system” based on the merits of the product and by leveraging their relationship, which includes trust. And by the way if you are going in promoting a broad formulary message like “all your UHC patients can get product x” then you are not credible; there are almost always carve out and exceptions; again if you have sold the provider they have in their mind resolved that the benefits outweigh the potential hassle factor in prescribing.
Stop! Pharma reps are not salespeople. What you just described is "influencing," to impel. Only the pharma industry believes that the sales reps are salespeople. You all are told what to say, when to say it, how to say it, and to whom. There's little thinking involved. You're a marketer. Nothing, more.
As in CologuardLooks like shit